Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Osteoporos Int. 2020 Jan 14;31(6):1105–1114. doi: 10.1007/s00198-019-05275-1

Table 4.

Mixed effects ANCOVA models for the outcomes

Outcomes Effects Model Estimate (SE) p-value

FNW (cm) Baseline FN width(cm) 0.8627(0.0208) <0.0001
Group (Vitamin D vs. Placebo) 0.0111(0.0183) 0.545
Time (month) 0.0005(0.0005) 0.326
time * group (vitamin D) −0.0004(0.0006) 0.487
FN BMD (g/cm2) Baseline FN BMD 0.9773(0.0133) <0.0001
Group (Vitamin D vs. Placebo) 0.0049(0.0045) 0.272
Time (month) −0.0005(0.0001) <0.0001
time * group (vitamin D) −9.95E-7(0.0001) 0.995
CSI (g/kg*m) Baseline CSI, (g/kg*m) 0.9054(0.0238) <0.0001
Group (Vitamin D vs. Placebo) 0.0292(0.0379) 0.442
Time (month) 0.0006(0.0007) 0.523
Time * group (vitamin D) − 0.0018(0.0010) 0.079
BSI (g/kg*m) Baseline BSI (g/kg*m) 0.8751(0.0255) <0.0001
Group (Vitamin D vs. Placebo) 0.0012(0.0017) 0.485
Time (month) 0.00004(0.00004) 0.829
time * group (vitamin D) −0.0001(0.0001) 0.096
ISI (g/kg*m) Baseline ISI, (g/kg*m) 0.9089(0.0230) <0.0001
Group (Vitamin D vs. Placebo) 0.0073(0.0241) 0.764
Time (month) 0.0006(0.0005) 0.627
Time * group (vitamin D) −0.0008(0.0007) 0.234

FNW-Femoral Neck Width; FN-Femoral Neck; BMD-Bone Mineral Density; CSI- Compression Strength Index; BSI- Bending Strength Index; Impact Strength Index; ANCOVA-Analysis of Covariance